Literature DB >> 2409981

Vascular, plasma membrane aminopeptidase M. Metabolism of vasoactive peptides.

F E Palmieri, J J Petrelli, P E Ward.   

Abstract

Aminopeptidase M (EC 3.4.11.2), an enzyme present on the cell surface of vascular endothelium and/or smooth muscle, rapidly hydrolyzes leucyl- and arginyl-2-naphthylamides and a number of vasoactive peptides at physiologic pH. Utilizing both thin-layer chromatography and high pressure liquid chromatography, it was found that vascular aminopeptidase M converted kallidin to bradykinin and inactivated des(Asp1)angiotensin I, angiotensin III, hepta(5-11)substance P and hexa(6-11)substance P. Aminopeptidase M did not, however, hydrolyze bradykinin, angiotensin I, angiotensin II, saralasin, vasopressin, oxytocin or any form of substance P containing a component of the Arg-Pro-Lys-Pro sequence. Both the naphthylamidase and peptidase activities were inhibited similarly by known amino-peptidase M inhibitors including o-phenanthroline, amastatin, bestatin and puromycin. However, inhibitors of angiotensin I converting enzyme (captopril), carboxypeptidase N (MERGETPA), neutral endopeptidase (phosphoramidon), post proline cleaving enzyme and dipeptidyl(amino)peptidase IV (diisopropylphosphofluoridate, DFP) were without effect. These results demonstrate that vascular, cell surface aminopeptidase M can selectively metabolize vasoactive peptides and may play a role in modulating their levels in the circulation and/or within the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409981     DOI: 10.1016/0006-2952(85)90787-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Structure and activity of CPNGRC: a modified CD13/APN peptidic homing motif.

Authors:  Leigh A Plesniak; Bridget Salzameda; Holly Hinderberger; Elizabeth Regan; James Kahn; Stephen A Mills; Peter Teriete; Yong Yao; Patricia Jennings; Francesca Marassi; Joseph A Adams
Journal:  Chem Biol Drug Des       Date:  2010-03-30       Impact factor: 2.817

2.  Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues.

Authors:  Paola Di Matteo; Gian Luigi Arrigoni; Luca Alberici; Angelo Corti; Corrado Gallo-Stampino; Catia Traversari; Claudio Doglioni; Gian-Paolo Rizzardi
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

3.  Methionyl aminopeptidase from rat liver: distribution of the membrane-bound subcellular enzyme.

Authors:  C Termignoni; J O Freitas Júnior; J A Guimarães
Journal:  Mol Cell Biochem       Date:  1991-04-10       Impact factor: 3.396

4.  Aminopeptidase activity in the jejunal and ileal Peyer's patches of the albino rabbit.

Authors:  E Hayakawa; V H Lee
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

5.  Neutral endopeptidase activity is not elevated in serum in children with cholestatic liver disease: a unique role of aminopeptidase-m in sequential hydrolysis of peptides.

Authors:  Roman M Janas; Jerzy Socha; Jadwiga Janas; Krzysztof Warnawin
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

6.  First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [125I]RB 129.

Authors:  F Noble; G Banisadr; F Jardinaud; T Popovici; R Lai-Kuen; H Chen; L Bischoff; S M Parsadaniantz; M C Fournie-Zaluski; B P Roques
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 7.  Aminopeptidase N in arterial hypertension.

Authors:  Robert S Danziger
Journal:  Heart Fail Rev       Date:  2007-11-16       Impact factor: 4.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.